{"id":"https://openalex.org/W2045603552","doi":"https://doi.org/10.1097/00002030-199811000-00001","title":"Activity of the soft gelatin formulation of saquinavir in combination therapy in antiretroviral-naive patients","display_name":"Activity of the soft gelatin formulation of saquinavir in combination therapy in antiretroviral-naive patients","publication_year":1998,"publication_date":"1998-07-01","ids":{"openalex":"https://openalex.org/W2045603552","doi":"https://doi.org/10.1097/00002030-199811000-00001","mag":"2045603552","pmid":"https://pubmed.ncbi.nlm.nih.gov/9708399"},"language":"en","primary_location":{"id":"doi:10.1097/00002030-199811000-00001","doi":"https://doi.org/10.1097/00002030-199811000-00001","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002030-199811000-00001","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087813701","display_name":"Ronald T. Mitsuyasu","orcid":"https://orcid.org/0000-0002-2627-6246","observed_orcids":["https://orcid.org/0000-0002-2627-6246"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ronald T. Mitsuyasu","raw_affiliation_strings":["University of California, Los Angeles, USA","Requests for reprints to: Dr Ronald T. Mitsuyasu, UCLA AIDS Clinical Research Center, Department of Medicine, BH-412 CHS, 10833 Le Conte Avenue, Los Angeles CA 90095-1793, USA","University of California, Los Angeles, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Los Angeles, USA","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"Requests for reprints to: Dr Ronald T. Mitsuyasu, UCLA AIDS Clinical Research Center, Department of Medicine, BH-412 CHS, 10833 Le Conte Avenue, Los Angeles CA 90095-1793, USA","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"University of California, Los Angeles, California, USA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091652325","display_name":"Paul R. Skolnik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I121934306","display_name":"Tufts University","ror":"https://ror.org/05wvpxv85","country_code":"US","type":"education","lineage":["https://openalex.org/I121934306"]},{"id":"https://openalex.org/I1290900354","display_name":"Tufts Medical Center","ror":"https://ror.org/002hsbm82","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1290900354"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul R. Skolnik","raw_affiliation_strings":["Tufts University\u2013New England Medical Center, Boston, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tufts University\u2013New England Medical Center, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I121934306","https://openalex.org/I1290900354"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077778132","display_name":"Stuart R. Cohen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160527","display_name":"University of California Davis Medical Center","ror":"https://ror.org/05t6gpm70","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160527","https://openalex.org/I4210160856"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stuart R. Cohen","raw_affiliation_strings":["University of California Davis Medical Center, Sacramento, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California Davis Medical Center, Sacramento, California, USA","institution_ids":["https://openalex.org/I4210160527"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101537673","display_name":"Brian Conway","orcid":"https://orcid.org/0000-0001-9930-7587","observed_orcids":["https://orcid.org/0000-0001-9930-7587"]},"institutions":[{"id":"https://openalex.org/I2801362399","display_name":"St. Paul's Hospital","ror":"https://ror.org/00wzdr059","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801362399"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Brian Conway","raw_affiliation_strings":["St Paul's Hospital, Vancouver, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St Paul's Hospital, Vancouver, Canada","institution_ids":["https://openalex.org/I2801362399"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065094327","display_name":"Michael John Gill","orcid":"https://orcid.org/0000-0002-8546-8790","observed_orcids":["https://orcid.org/0000-0002-8546-8790"]},"institutions":[{"id":"https://openalex.org/I168635309","display_name":"University of Calgary","ror":"https://ror.org/03yjb2x39","country_code":"CA","type":"education","lineage":["https://openalex.org/I168635309"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"M John Gill","raw_affiliation_strings":["University of Calgary, Calgary, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Calgary, Calgary, Canada","institution_ids":["https://openalex.org/I168635309"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089625551","display_name":"Peter Jensen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1315708478","display_name":"San Francisco VA Medical Center","ror":"https://ror.org/049peqw80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315708478","https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210125474","https://openalex.org/I4210143381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter C. Jensen","raw_affiliation_strings":["Veterans' Affairs Medical Center, San Francisco, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Veterans' Affairs Medical Center, San Francisco, California, USA","institution_ids":["https://openalex.org/I1315708478"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088341827","display_name":"Joseph Pulvirenti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799932517","display_name":"John H. Stroger, Jr. Hospital of Cook County","ror":"https://ror.org/05626m728","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799932517"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph J. Pulvirenti","raw_affiliation_strings":["Cook County Hospital, Chicago, Illinois, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cook County Hospital, Chicago, Illinois, USA","institution_ids":["https://openalex.org/I2799932517"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107843639","display_name":"Leonard N. Slater","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I49332381","display_name":"University of Oklahoma Health Sciences Center","ror":"https://ror.org/0457zbj98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I49332381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leonard N. Slater","raw_affiliation_strings":["University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, USA","institution_ids":["https://openalex.org/I49332381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108096940","display_name":"Robert T. Schooley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert T. Schooley","raw_affiliation_strings":["University of Colorado, Denver, Colorado, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado, Denver, Colorado, USA","institution_ids":["https://openalex.org/I921990950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079664351","display_name":"Melanie Thompson","orcid":"https://orcid.org/0009-0005-0341-2400","observed_orcids":["https://orcid.org/0009-0005-0341-2400"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I4210092916","display_name":"AIDS Research Consortium of Atlanta","ror":"https://ror.org/00g0gdw57","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210092916"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melanie A. Thompson","raw_affiliation_strings":["University of California, Los Angeles, California, USA","AIDS Research Consortium of Atlanta, Atlanta, Georgia, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Los Angeles, California, USA","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"AIDS Research Consortium of Atlanta, Atlanta, Georgia, USA","institution_ids":["https://openalex.org/I4210092916"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109247645","display_name":"Ram\u00f3n Alberto de Torres","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I4210091615","display_name":"Saint Vincent's Catholic Medical Center","ror":"https://ror.org/00cwrhn79","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210091615"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ramon A. Torres","raw_affiliation_strings":["University of California, Los Angeles, California, USA","St Vincent's Hospital and Medical Center, New York, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Los Angeles, California, USA","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"St Vincent's Hospital and Medical Center, New York, New York, USA","institution_ids":["https://openalex.org/I4210091615"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5058280123","display_name":"Christos Micheal Tsoukas","orcid":"https://orcid.org/0009-0008-0628-9542","observed_orcids":["https://orcid.org/0009-0008-0628-9542"]},"institutions":[{"id":"https://openalex.org/I121934306","display_name":"Tufts University","ror":"https://ror.org/05wvpxv85","country_code":"US","type":"education","lineage":["https://openalex.org/I121934306"]},{"id":"https://openalex.org/I1290900354","display_name":"Tufts Medical Center","ror":"https://ror.org/002hsbm82","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1290900354"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I2800293973","display_name":"Montreal General Hospital","ror":"https://ror.org/04gbhgc79","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2800293973","https://openalex.org/I2801766832","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405279980"]}],"countries":["CA","US"],"is_corresponding":false,"raw_author_name":"Christos M. Tsoukas","raw_affiliation_strings":["Date of receipt: 12 March 1998; revised: 1 May 1998, accepted: 5 May 1998","Sponsorship: This work was supported by Hoffmann\u2013La Roche","Tufts University\u2013New England Medical Center, Boston, Massachusetts, USA","University of California, Los Angeles, California, USA","Montreal General Hospital, Montreal, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Date of receipt: 12 March 1998; revised: 1 May 1998, accepted: 5 May 1998","institution_ids":[]},{"raw_affiliation_string":"Sponsorship: This work was supported by Hoffmann\u2013La Roche","institution_ids":[]},{"raw_affiliation_string":"Tufts University\u2013New England Medical Center, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I121934306","https://openalex.org/I1290900354"]},{"raw_affiliation_string":"University of California, Los Angeles, California, USA","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"Montreal General Hospital, Montreal, Canada","institution_ids":["https://openalex.org/I2800293973"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":13,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":7.7871,"has_fulltext":false,"cited_by_count":50,"citation_normalized_percentile":{"value":0.97638889,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":95},"biblio":{"volume":"12","issue":"11","first_page":"F103","last_page":"F109"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/saquinavir","display_name":"saquinavir","score":1.0},{"id":"https://openalex.org/keywords/soft-gelatin-capsules","display_name":"soft gelatin capsules","score":0.8450000286102295},{"id":"https://openalex.org/keywords/hard-gelatin-capsules","display_name":"hard gelatin capsules","score":0.9819999933242798},{"id":"https://openalex.org/keywords/hiv-1-infection","display_name":"HIV-1 infection","score":0.7120000123977661},{"id":"https://openalex.org/keywords/antiretroviral-naive-patients","display_name":"antiretroviral-naive patients","score":0.9340000152587891},{"id":"https://openalex.org/keywords/protease-inhibitors","display_name":"protease inhibitors","score":0.8629999756813049},{"id":"https://openalex.org/keywords/nucleoside-reverse-transcriptase-inhibitors","display_name":"nucleoside reverse transcriptase inhibitors","score":0.9800000190734863},{"id":"https://openalex.org/keywords/highly-active-antiretroviral-therapy","display_name":"highly active antiretroviral therapy","score":0.8920000195503235},{"id":"https://openalex.org/keywords/drug-formulation-comparison","display_name":"drug formulation comparison","score":0.8159999847412109},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.33500000834465027}],"concepts":[{"id":"https://openalex.org/C2776937687","wikidata":"https://www.wikidata.org/wiki/Q422654","display_name":"Saquinavir","level":5,"score":0.9269360899925232},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7253406047821045},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.5734957456588745},{"id":"https://openalex.org/C2781143361","wikidata":"https://www.wikidata.org/wiki/Q55761529","display_name":"Protease inhibitor (pharmacology)","level":5,"score":0.5302436351776123},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4976988136768341},{"id":"https://openalex.org/C2778823387","wikidata":"https://www.wikidata.org/wiki/Q179254","display_name":"Gelatin","level":2,"score":0.4781247675418854},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.4528832733631134},{"id":"https://openalex.org/C2777351918","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Reverse-transcriptase inhibitor","level":5,"score":0.4442320466041565},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.4380101263523102},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3643344044685364},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.27519136667251587},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.2343372106552124},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.12835049629211426},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003257","descriptor_name":"Consumer Product Safety","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005780","descriptor_name":"Gelatin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012367","descriptor_name":"RNA, Viral","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D017320","descriptor_name":"HIV Protease Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017320","descriptor_name":"HIV Protease Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018791","descriptor_name":"CD4 Lymphocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019258","descriptor_name":"Saquinavir","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019258","descriptor_name":"Saquinavir","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/00002030-199811000-00001","doi":"https://doi.org/10.1097/00002030-199811000-00001","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002030-199811000-00001","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},{"id":"pmid:9708399","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9708399","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS (London, England)","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W2007879783","https://openalex.org/W2012139740","https://openalex.org/W2014842368","https://openalex.org/W2164462848","https://openalex.org/W2339827976","https://openalex.org/W2618540258"],"related_works":["https://openalex.org/W4236812505","https://openalex.org/W2171550471","https://openalex.org/W1988199975","https://openalex.org/W2320123214","https://openalex.org/W2098913434","https://openalex.org/W1978607441","https://openalex.org/W2077438372","https://openalex.org/W2436986572","https://openalex.org/W1576185361","https://openalex.org/W2111172881"],"abstract_inverted_index":{"OBJECTIVE:":[0],"A":[1,44,102,184],"Phase":[2],"II,":[3],"open-label,":[4],"randomized,":[5],"parallel-arm,":[6],"multicentre":[7],"trial":[8],"to":[9,92,98,216],"compare":[10],"the":[11,93,99,178,189,192,197,231,234,237,240],"antiviral":[12],"activity":[13],"and":[14,25,79,96,199,222,255,263],"safety":[15],"of":[16,19,46,49,86,104,110,164,269],"two":[17,33,134],"formulations":[18],"saquinavir":[20],"(SQV),":[21],"soft":[22],"gelatin":[23,27],"(SQV-SGC)":[24],"hard":[26],"(SQV-HGC)":[28],"capsules,":[29],"in":[30,39,131,148,177,188,273],"combination":[31,132],"with":[32,55,117,133,175,224],"nucleoside":[34],"reverse":[35],"transcriptase":[36],"inhibitors":[37],"(NRTI),":[38],"antiretroviral-naive,":[40],"HIV-1-infected":[41],"individuals.":[42],"PARTICIPANTS:":[43],"total":[45,103],"171":[47],"people":[48,89],">":[50,60],"or":[51,61,73,122],"=":[52,62,74,182,209,247],"13":[53],"years,":[54],"plasma":[56,149,270],"HIV-1":[57,150,271],"RNA":[58,151,272],"levels":[59],"5000":[63],"copies/ml,":[64,206],"who":[65],"had":[66,144,168],"received":[67],"no":[68,80],"protease":[69],"inhibitor":[70],"therapy,":[71],"<":[72,169,225],"4":[75],"weeks":[76,109,116],"NRTI":[77],"therapy":[78],"antiretroviral":[81],"treatment":[82],"within":[83],"28":[84],"days":[85],"screening.":[87],"Eighty-one":[88],"were":[90,228],"randomized":[91],"SQV-HGC":[94,123,155,179,200],"group":[95,180],"90":[97],"SQV-SGC":[100,119,143,167,198,258],"group.":[101],"148":[105],"patients":[106,141,223,275],"completed":[107],"16":[108,115],"therapy.":[111],"INTERVENTION:":[112],"Therapy":[113],"for":[114,239],"either":[118],"1200":[120],"mg":[121],"600":[124],"mg,":[125],"both":[126],"three":[127],"times":[128],"a":[129,145],"day,":[130],"NRTI.":[135],"RESULTS:":[136],"Using":[137],"an":[138],"on-treatment":[139],"analysis,":[140],"taking":[142,154],"larger":[146],"reduction":[147],"than":[152,276],"those":[153,165],"(-2.0":[156],"versus":[157,203],"-1.6":[158],"log10":[159,205],"copies/ml).":[160],"Eighty":[161],"per":[162],"cent":[163],"on":[166],"400":[170],"copies":[171],"HIV":[172],"RNA/ml,":[173],"compared":[174],"43%":[176],"(P":[181,246],"0.001).":[183],"statistically":[185],"significant":[186,245],"difference":[187,235],"area":[190],"under":[191],"curve":[193],"(AUC)":[194],"values":[195,238],"between":[196,236],"arms":[201],"(-1.7":[202],"-1.5":[204],"respectively;":[207],"P":[208],"0.0054)":[210],"was":[211,243,259],"observed":[212],"when":[213],"withdrawals":[214],"prior":[215],"week":[217],"12,":[218],"major":[219],"protocol":[220],"violators":[221],"75%":[226],"compliance":[227],"excluded":[229],"from":[230],"analysis;":[232],"however,":[233],"intent-to-treat":[241],"population":[242],"not":[244],"0.1929).":[248],"Adverse":[249],"events":[250],"(mostly":[251],"mild)":[252],"included":[253],"diarrhoea":[254],"nausea.":[256],"CONCLUSIONS:":[257],"generally":[260],"well":[261],"tolerated":[262],"gave":[264],"significantly":[265],"more":[266],"potent":[267],"suppression":[268],"antiretroviral-naive":[274],"SQVHGC.":[277]},"counts_by_year":[{"year":2020,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}